Search research articles
Contact Us
Filters
Showing results (111-120 of 348) with videos related to
Page
of 35
Sort By:
European Journal of Medicinal Chemistry
|
September 18, 2007
Basic 3-hydroxypyridin-4-ones: potential antimalarial agents
Lotfollah S Dehkordi, Zu D Liu, Robert C Hider
The Journal of Pharmacy and Pharmacology
|
March 1, 1987
Effects of the pyrones, maltol and ethyl maltol, on iron absorption from the rat small intestine
M A Barrand, B A Callingham, R C Hider
ACS Omega
|
February 18, 2020
Synthetic Approaches for Piperidone-Based Templates as Scaffolds to Access Chirally Enriched Donepezil Analogues
Anna Poeschl, David M Mountford, Robert C Hider, et al.
The New Phytologist
|
April 20, 2021
Competition or complementation: the iron-chelating abilities of nicotianamine and phytosiderophores
Robert C Hider, Etsuro Yoshimura, Hicham Khodr, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1994
Iron chelator design
R C Hider, O Epemolu, S Singh, et al.
The Journal of Pharmacy and Pharmacology
|
June 4, 2011
Design of clinically useful macromolecular iron chelators
Tao Zhou, Günther Winkelmann, Zhi-Yuan Dai, et al.
Biochemical Society Symposium
|
January 1, 1995
Therapeutic iron chelators and their potential side-effects
S Singh, H Khodr, M I Taylor, et al.
Dalton Transactions (Cambridge, England : 2003)
|
October 15, 2014
Synthesis and characterizations of pyridazine-based iron chelators
Yongmin Ma, Xiaole Kong, Yu-lin Chen, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry
|
August 31, 2002
The iron-binding properties of aminochelin, the mono(catecholamide) siderophore of Azotobacter vinelandii
H H Khodr, R C Hider, A-K Duhme-Klair
Immunity, Inflammation and Disease
|
September 1, 2020
HPO iron chelator, CP655, causes the G1/S phase cell cycle block via p21 upregulation
Damini Tewari, Katie Lloyd-Jones, Robert C Hider, et al.
Page
of 35
Search research articles
Search
Showing results (111-120 of 348) with videos related to
Sort By:
Page
of 35
European Journal of Medicinal Chemistry
|
September 18, 2007
Basic 3-hydroxypyridin-4-ones: potential antimalarial agents
Lotfollah S Dehkordi, Zu D Liu, Robert C Hider
The Journal of Pharmacy and Pharmacology
|
March 1, 1987
Effects of the pyrones, maltol and ethyl maltol, on iron absorption from the rat small intestine
M A Barrand, B A Callingham, R C Hider
ACS Omega
|
February 18, 2020
Synthetic Approaches for Piperidone-Based Templates as Scaffolds to Access Chirally Enriched Donepezil Analogues
Anna Poeschl, David M Mountford, Robert C Hider, et al.
The New Phytologist
|
April 20, 2021
Competition or complementation: the iron-chelating abilities of nicotianamine and phytosiderophores
Robert C Hider, Etsuro Yoshimura, Hicham Khodr, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1994
Iron chelator design
R C Hider, O Epemolu, S Singh, et al.
The Journal of Pharmacy and Pharmacology
|
June 4, 2011
Design of clinically useful macromolecular iron chelators
Tao Zhou, Günther Winkelmann, Zhi-Yuan Dai, et al.
Biochemical Society Symposium
|
January 1, 1995
Therapeutic iron chelators and their potential side-effects
S Singh, H Khodr, M I Taylor, et al.
Dalton Transactions (Cambridge, England : 2003)
|
October 15, 2014
Synthesis and characterizations of pyridazine-based iron chelators
Yongmin Ma, Xiaole Kong, Yu-lin Chen, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry
|
August 31, 2002
The iron-binding properties of aminochelin, the mono(catecholamide) siderophore of Azotobacter vinelandii
H H Khodr, R C Hider, A-K Duhme-Klair
Immunity, Inflammation and Disease
|
September 1, 2020
HPO iron chelator, CP655, causes the G1/S phase cell cycle block via p21 upregulation
Damini Tewari, Katie Lloyd-Jones, Robert C Hider, et al.
Page
of 35